Principal Financial Group Inc. Trims Holdings in The Cooper Companies, Inc. (NASDAQ:COO)

Principal Financial Group Inc. decreased its holdings in shares of The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 4.0% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 227,405 shares of the medical device company's stock after selling 9,452 shares during the period. Principal Financial Group Inc. owned 0.11% of Cooper Companies worth $19,182,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently made changes to their positions in the business. Proficio Capital Partners LLC bought a new position in Cooper Companies in the fourth quarter worth approximately $95,000. Jones Financial Companies Lllp boosted its holdings in Cooper Companies by 227.7% in the fourth quarter. Jones Financial Companies Lllp now owns 970 shares of the medical device company's stock worth $89,000 after acquiring an additional 674 shares in the last quarter. Steward Partners Investment Advisory LLC boosted its holdings in Cooper Companies by 19.1% in the fourth quarter. Steward Partners Investment Advisory LLC now owns 1,407 shares of the medical device company's stock worth $129,000 after acquiring an additional 226 shares in the last quarter. Daiwa Securities Group Inc. boosted its holdings in Cooper Companies by 6.5% in the fourth quarter. Daiwa Securities Group Inc. now owns 33,894 shares of the medical device company's stock worth $3,116,000 after acquiring an additional 2,083 shares in the last quarter. Finally, EverSource Wealth Advisors LLC boosted its holdings in Cooper Companies by 9.0% in the fourth quarter. EverSource Wealth Advisors LLC now owns 6,297 shares of the medical device company's stock worth $579,000 after acquiring an additional 518 shares in the last quarter. Institutional investors own 24.39% of the company's stock.

Wall Street Analysts Forecast Growth

A number of research analysts have recently weighed in on the company. Loop Capital set a $100.00 target price on Cooper Companies in a report on Tuesday, June 17th. Needham & Company LLC upgraded Cooper Companies from a "hold" rating to a "buy" rating and set a $94.00 target price on the stock in a report on Tuesday, June 17th. JPMorgan Chase & Co. restated a "neutral" rating and issued a $76.00 target price (down previously from $110.00) on shares of Cooper Companies in a report on Friday, May 30th. Wall Street Zen lowered Cooper Companies from a "buy" rating to a "hold" rating in a report on Saturday. Finally, UBS Group upgraded Cooper Companies to a "buy" rating in a report on Tuesday, June 17th. Four equities research analysts have rated the stock with a hold rating and eight have issued a buy rating to the company. According to MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average target price of $99.70.

Cooper Companies Stock Performance

NASDAQ:COO traded down $1.93 during trading hours on Friday, reaching $74.77. The stock had a trading volume of 2,517,933 shares, compared to its average volume of 1,742,225. The company has a debt-to-equity ratio of 0.30, a quick ratio of 1.23 and a current ratio of 2.10. The stock has a 50 day simple moving average of $74.92 and a 200 day simple moving average of $82.64. The Cooper Companies, Inc. has a 12-month low of $65.00 and a 12-month high of $112.38. The stock has a market cap of $14.95 billion, a P/E ratio of 36.30, a price-to-earnings-growth ratio of 1.82 and a beta of 0.99.

Cooper Companies (NASDAQ:COO - Get Free Report) last released its earnings results on Thursday, May 29th. The medical device company reported $0.96 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.93 by $0.03. Cooper Companies had a return on equity of 9.60% and a net margin of 10.39%. The business had revenue of $1 billion during the quarter, compared to the consensus estimate of $995.12 million. During the same period last year, the business posted $0.85 earnings per share. The business's revenue for the quarter was up 6.3% on a year-over-year basis. On average, research analysts forecast that The Cooper Companies, Inc. will post 3.98 EPS for the current fiscal year.

Cooper Companies Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.